Compare
SyRev focuses on AI title/abstract screening you can defend, with full text on Plus and newly launched data extraction. Rayyan, Covidence and DistillerSR are full review platforms. Here's a plain comparison, with every competitor detail sourced.
| SyRev | Rayyan | Covidence | DistillerSR | |
|---|---|---|---|---|
| Price (public list) | 2 free evaluations, then Replay $149 or Plus $249 per review · Team $29/seat/mo · Department $2,500/yr (up to 10 named users) · University $9,000/yr (up to 150 named users) · Large from $15,000/yr · academic prices (commercial pricing) | Free plan (3 active reviews) · Essential and Advanced from $4.99 and $8.33 per seat/mo billed annually · Business/Academic $41.67/licence/mo billed annually, from 5 licences · Enterprise custom[1] | Free trial (500 records) · single-review and multi-review plans, see Covidence’s pricing page · institutional licences on enquiry[3] | Academic: Student $19.95/mo · Faculty $94/mo and Research Project $194/mo, billed annually · departmental, institutional and commercial on enquiry[7] |
| AI screening | Scores each title/abstract against your criteria and auto-excludes only clear exclusions (Careful mode); people screen the rest | AI relevance predictions on all plans · ResearchPilot AI Reviewer screens against your criteria as a team member, on Business/Academic and Enterprise[1][2] | Active-learning "most relevant" sorting (people still screen everything) · RCT classifier can tag or remove non-RCTs in health reviews[5] | AI reprioritisation, AI double-check of exclusions, custom classifiers, and Smart Screening (human-in-the-loop or fully automated)[8] |
| Validation evidence | 96.5% recall at Careful on public benchmark reviews; individual reviews can be lower · per-review validation pack (blind sample + Wilson CI) | Not stated publicly on the pages we checked | RCT classifier with high reported recall, evaluated on English-language biomedical records[5] · published an account of an LLM auto-exclude feature it chose not to release[6] | Cites published evaluations and customer case studies on its AI page[8] |
| PRISMA | PRISMA 2020 diagram with AI and human exclusions shown separately, plus reports not retrieved and full-text exclusions with reasons and counts · SVG/PNG/PDF · New PRISMA-S search log with CSV export (every plan) | PRISMA flow diagrams on Essential and above; PRISMA 2020 report listed in plan comparison[1] | PRISMA flow diagram built from your decisions; updates to show automated RCT-classifier exclusions[4][5] | PRISMA flow diagram among standard reports[9] |
| Full-text screening | New Human full-text screening on every plan, including the free evaluations: PDF open while you vote, single or dual, a structured reason for every exclusion · AI full-text screening on Plus, as second reviewer or suggestion | Full-text screening stage; Auto Match PDF and Auto Retrieve PDF listed under AI & automation (plan availability not clear from the public table)[1] | Full-text screening; automatic upload of open-access PDFs via Unpaywall using the DOI[10] | Automatic PDF search through DOI.org, compatible with the Unpaywall plugin, RightFind and Article Galaxy integrations[7] |
| Dual review | AI as second reviewer (every plan, including free evaluations), or two human reviewers (Team and institutional plans) · blinded until both have screened: AI decision, other reviewer’s votes, exports and PRISMA diagram hidden · two human reviewers can be named, any two workspace members, or a reproducible random split across a reviewer pool · resolve step for disagreements · raw agreement and Cohen’s kappa reported | Blinding, collaborators and a kappa report; the ResearchPilot AI Reviewer can join as an additional screener (Business/Academic and Enterprise)[1][2] | Independent dual screening, blinding and structured conflict resolution as standard[4] | Dual reviewer screening and conflict resolution[9] |
| Deduplication | Import RIS, PubMed .nbib, EndNote XML or CSV, up to 10 files at once, or search PubMed, OpenAlex and Europe PMC from inside SyRev (every plan) · deduplication automatic across all files, before screening (every plan): clear matches (exact DOI/PMID/PMCID, or near-identical title with the same year and first author) merged; possible matches go to a check screen (merge or keep both); merges can be undone; removed records are not screened or counted toward usage; the count feeds the PRISMA 2020 diagram | Duplicate detection on all plans; auto-resolve from Essential up[1] | Duplicates removed automatically on import[4] | Duplicate detection[9] |
| Data extraction | New Manual extraction on every plan, including the free evaluations · with Plus: AI pre-fill and an AI second extractor with compare-and-resolve (up to 500 studies per review), with an exact quote and page number on every suggested answer · CSV, Excel, blank form and RevMan Web pack exports | Data extraction stage and report; AI PICO extraction from Advanced up[1] | Reusable extraction templates, with LLM suggestions that must be verified[4][5] | Configurable extraction forms, including generative-AI Smart Evidence Extraction[9][8] |
Competitor details are from their public websites on 25 September 2026; numbered links go to the sources below. SyRev recall figure: 96.5% recall at Careful, measured on public benchmark datasets. It is pooled across all 9,707 relevant studies in 310 datasets, not a per-review guarantee. See full results
Each page covers pricing, AI, reporting, where each tool is strong, and what's new at SyRev.
A free, widely used screening platform with an AI reviewer on institutional plans.
Compare SyRev and Rayyan →AI pre-screening before you import into Covidence, which covers the full systematic-review workflow with deliberately cautious AI.
Using SyRev with Covidence →Highly configurable, audit-heavy software used in regulatory and enterprise reviews.
Compare SyRev and DistillerSR →Competitor details come from their public websites on the date above and can change. If something here is out of date, tell us and we'll correct it.